These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 27392635)
1. The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia. Ralvenius WT; Acuña MA; Benke D; Matthey A; Daali Y; Rudolph U; Desmeules J; Zeilhofer HU; Besson M Neuropharmacology; 2016 Oct; 109():366-375. PubMed ID: 27392635 [TBL] [Abstract][Full Text] [Related]
2. GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers. Matthey A; Daali Y; Curtin F; Poncet A; Desmeules J; Besson M Eur J Pain; 2020 Jul; 24(6):1094-1106. PubMed ID: 32171038 [TBL] [Abstract][Full Text] [Related]
3. Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study. Besson M; Daali Y; Di Lio A; Dayer P; Zeilhofer HU; Desmeules J Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):192-7. PubMed ID: 23006671 [TBL] [Abstract][Full Text] [Related]
4. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain. Di Lio A; Benke D; Besson M; Desmeules J; Daali Y; Wang ZJ; Edwankar R; Cook JM; Zeilhofer HU Neuropharmacology; 2011 Mar; 60(4):626-32. PubMed ID: 21145329 [TBL] [Abstract][Full Text] [Related]
5. Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites. Paul J; Yévenes GE; Benke D; Di Lio A; Ralvenius WT; Witschi R; Scheurer L; Cook JM; Rudolph U; Fritschy JM; Zeilhofer HU Neuropsychopharmacology; 2014 Jan; 39(2):477-87. PubMed ID: 24045508 [TBL] [Abstract][Full Text] [Related]
6. Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype. Ralvenius WT; Benke D; Acuña MA; Rudolph U; Zeilhofer HU Nat Commun; 2015 Apr; 6():6803. PubMed ID: 25865415 [TBL] [Abstract][Full Text] [Related]
7. GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers. Besson M; Matthey A; Daali Y; Poncet A; Vuillemier P; Curatolo M; Zeilhofer HU; Desmeules J Pain; 2015 Mar; 156(3):397-404. PubMed ID: 25687539 [TBL] [Abstract][Full Text] [Related]
8. TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via α2GABA Neumann E; Ralvenius WT; Acuña MA; Rudolph U; Zeilhofer HU Neuropharmacology; 2018 Dec; 143():71-78. PubMed ID: 30240781 [TBL] [Abstract][Full Text] [Related]
9. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. Sankar R CNS Drugs; 2012 Mar; 26(3):229-44. PubMed ID: 22145708 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA Fischer BD; Schlitt RJ; Hamade BZ; Rehman S; Ernst M; Poe MM; Li G; Kodali R; Arnold LA; Cook JM Brain Res Bull; 2017 May; 131():62-69. PubMed ID: 28267561 [TBL] [Abstract][Full Text] [Related]
11. Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice. Knabl J; Zeilhofer UB; Crestani F; Rudolph U; Zeilhofer HU Pain; 2009 Feb; 141(3):233-238. PubMed ID: 19091469 [TBL] [Abstract][Full Text] [Related]
12. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Atack JR Expert Opin Investig Drugs; 2005 May; 14(5):601-18. PubMed ID: 15926867 [TBL] [Abstract][Full Text] [Related]
13. N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy? Haigh JR; Pullar T; Gent JP; Dailley C; Feely M Br J Clin Pharmacol; 1987 Feb; 23(2):213-8. PubMed ID: 3828198 [TBL] [Abstract][Full Text] [Related]
14. GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics. Atack JR Curr Top Med Chem; 2011; 11(9):1176-202. PubMed ID: 21050172 [TBL] [Abstract][Full Text] [Related]
15. Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes. Hammer H; Ebert B; Jensen HS; Jensen AA PLoS One; 2015; 10(3):e0120239. PubMed ID: 25798598 [TBL] [Abstract][Full Text] [Related]
16. Restoring the spinal pain gate: GABA(A) receptors as targets for novel analgesics. Zeilhofer HU; Ralvenius WT; Acuña MA Adv Pharmacol; 2015; 73():71-96. PubMed ID: 25637438 [TBL] [Abstract][Full Text] [Related]
18. [Behavioral and electroencephalographic study of 7-chloro-1-methyl-5-phenyl-1 H-1,5-benzodiazepine-2,4-(3H,5H)-dione (clobazam)]. Gomita Y; Morii M; Ichimaru Y; Moriyama M; Ueki S Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):267-92. PubMed ID: 6662418 [TBL] [Abstract][Full Text] [Related]
19. The effect of cimetidine on the single dose pharmacokinetics of oral clobazam and N-desmethylclobazam. Pullar T; Edwards D; Haigh JR; Peaker S; Feely MP Br J Clin Pharmacol; 1987 Mar; 23(3):317-21. PubMed ID: 3567046 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study. Vuilleumier PH; Besson M; Desmeules J; Arendt-Nielsen L; Curatolo M PLoS One; 2013; 8(3):e43896. PubMed ID: 23554851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]